These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 19432812)
21. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease. Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021 [TBL] [Abstract][Full Text] [Related]
22. Overview on rodent models of Alzheimer's disease. Dodart JC; May P Curr Protoc Neurosci; 2005 Nov; Chapter 9():Unit 9.22. PubMed ID: 18428631 [TBL] [Abstract][Full Text] [Related]
29. Cellular and molecular biology of Alzheimer's disease and animal models. Price DL; Sisodia SS Annu Rev Med; 1994; 45():435-46. PubMed ID: 8198393 [TBL] [Abstract][Full Text] [Related]
30. AβPP-overexpressing transgenic rat model of Alzheimer's disease utilizing the Tg2576 mouse protocol. O'Hare E; Ardis T; Page D; Scopes DI; Kim EM J Alzheimers Dis; 2013; 37(1):77-88. PubMed ID: 23780661 [TBL] [Abstract][Full Text] [Related]
31. The role of beta-amyloid in Alzheimer's disease. Sinha S Med Clin North Am; 2002 May; 86(3):629-39. PubMed ID: 12168562 [TBL] [Abstract][Full Text] [Related]
32. Neuropathological and behavioral features of an APP/PS1/MAPT (6xTg) transgenic model of Alzheimer's disease. Tag SH; Kim B; Bae J; Chang KA; Im HI Mol Brain; 2022 Jun; 15(1):51. PubMed ID: 35676711 [TBL] [Abstract][Full Text] [Related]
33. Probing the biology of Alzheimer's disease in mice. Ashe KH; Zahs KR Neuron; 2010 Jun; 66(5):631-45. PubMed ID: 20547123 [TBL] [Abstract][Full Text] [Related]
37. Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease. Klakotskaia D; Agca C; Richardson RA; Stopa EG; Schachtman TR; Agca Y PLoS One; 2018; 13(4):e0195469. PubMed ID: 29641600 [TBL] [Abstract][Full Text] [Related]
38. [Selected mice models based on APP, MAPT and presenilin gene mutations in research on the pathogenesis of Alzheimer's disease]. Więdłocha M; Stańczykiewicz B; Jakubik M; Rymaszewska J Postepy Hig Med Dosw (Online); 2012 Jun; 66():415-30. PubMed ID: 22922141 [TBL] [Abstract][Full Text] [Related]
39. A novel rat model of Alzheimer's disease based on lentiviral-mediated expression of mutant APP. Parsi S; Pandamooz S; Heidari S; Naji M; Morfini G; Ahmadiani A; Dargahi L Neuroscience; 2015 Jan; 284():99-106. PubMed ID: 25270904 [TBL] [Abstract][Full Text] [Related]
40. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Yang DS; Stavrides P; Mohan PS; Kaushik S; Kumar A; Ohno M; Schmidt SD; Wesson D; Bandyopadhyay U; Jiang Y; Pawlik M; Peterhoff CM; Yang AJ; Wilson DA; St George-Hyslop P; Westaway D; Mathews PM; Levy E; Cuervo AM; Nixon RA Brain; 2011 Jan; 134(Pt 1):258-77. PubMed ID: 21186265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]